Program

Collapse All

June 10, 2021

10:00 AM - 10:10 AM

Welcome

  • Description
  • Richard J Willke, PhD, Chief Science Officer, ISPOR, Lawrenceville, NJ, USA


June 10, 2021

10:10 AM - 11:20 AM

Session 1: Expanding the Use of Patient and Societal Considerations in Value Assessment

  • Description
  • Moderator

    Alan J. Balch, PhD, CEO, Patient Advocate Foundation and National Patient Advocate, Foundation, Washington, DC, USA



June 10, 2021

11:20 AM - 11:30 AM

Break

June 10, 2021

11:30 AM - 12:30 PM

Session 2: Incorporation of Uncertainty and Risk Aversion into Value Assessment

  • Description
  • Moderator

    Louis P. Garrison, Jr. PhD, Professor, Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, and Adjunct Professor, the Departments of Global Health and Health Services, University of Washington, Seattle, WA, USA.



June 10, 2021

12:30 PM - 12:40 PM

Break

June 10, 2021

12:40 PM - 1:40 PM

Session 3: Value Assessment in Decision-making

  • Description
  • Moderator

    Edmund Pezalla, MD, MPH, Founder and CEO, Enlightenment Bioconsult, Wethersfield, CT, USA



June 10, 2021

1:40 PM - 1:50 PM

Closing Remarks

June 10, 2021

1:50 PM - 2:00 PM

Break

June 10, 2021

2:00 PM - 3:00 PM

Sponsored Symposia – Value Assessment